Skip Navigation

NIH VideoCasting

CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.

A new day for drug development in neuroscience

Loading video...

502 Views  
   
Air date: Wednesday, June 24, 2015, 3:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 502, (168 Live, 334 On-demand)
Category: WALS - Wednesday Afternoon Lectures
Runtime: 01:12:18
Description: Wednesday Afternoon Lecture Series (WALS)

Dr. Dolmetsch's group is responsible for leveraging advances in human genetics to model and treat neuropsychiatric and neurodegenerative diseases. Areas of focus include genomics, induced pluripotent stem cells, and brain circuitry.

Dr. Dolmetsch joined Novartis in August 2013 from the Stanford University School of Medicine, where he was an associate professor of neurobiology. He was also the senior director of Molecular Networks at the Allen Institute for Brain Research. He studied the molecular roots of autism and other neurodevelopmental disorders, including the role of calcium-channel signaling. His laboratory recently used induced pluripotent stem cells to develop an in vitro model of Timothy syndrome, a rare disease with a variety of symptoms, including the characteristic features of autism.

For more information go to https://oir.nih.gov/wals
Debug: Show Debug
NLM Title: A new day for drug development in neuroscience / Ricardo Dolmetsch.
Author: Dolmetsch, Ricardo E.
National Institutes of Health (U.S.),
Publisher:
Abstract: (CIT): Wednesday Afternoon Lecture Series (WALS) Dr. Dolmetsch's group is responsible for leveraging advances in human genetics to model and treat neuropsychiatric and neurodegenerative diseases. Areas of focus include genomics, induced pluripotent stem cells, and brain circuitry. Dr. Dolmetsch joined Novartis in August 2013 from the Stanford University School of Medicine, where he was an associate professor of neurobiology. He was also the senior director of Molecular Networks at the Allen Institute for Brain Research. He studied the molecular roots of autism and other neurodevelopmental disorders, including the role of calcium-channel signaling. His laboratory recently used induced pluripotent stem cells to develop an in vitro model of Timothy syndrome, a rare disease with a variety of symptoms, including the characteristic features of autism.
Subjects: Drug Delivery Systems
Drug Discovery
Mental Disorders--drug therapy
Neurodegenerative Diseases--drug therapy
Publication Types: Lecture
Webcast
Download: To download this event, select one of the available bitrates:
[64k]  [150k]  [240k]  [440k]  [740k]  [1040k]  [1240k]  [1440k]  [1840k]    How to download a Videocast
Caption Text: Download Caption File
NLM Classification: WM 402
NLM ID: 101665638
CIT Live ID: 16428
Permanent link: https://videocast.nih.gov/watch=16428